A T D Ozcan1, C B Altin2, S Erdogan3, M Ergin3, A Çiftçi4, H Kara5, S M Aksoy2, A But2. 1. Atatürk Training and Research Hospital, Anesthesiology and Reanimation Department, Atatürk Training and Research Hospital, Bilkent, Ankara, Turkey. draycaozcan@gmail.com. 2. Yıldırım Beyazıt University Anesthesiology and Reanimation Department, Ankara, Turkey. 3. Atatürk Training and Research Hospital, Biochemistry Department, Ankara, Turkey. 4. Atatürk Training and Research Hospital, Anesthesiology and Reanimation Department, Atatürk Training and Research Hospital, Bilkent, Ankara, Turkey. 5. Yıldırım Beyazıt University Pharmacology Department, Ankara, Turkey.
Abstract
BACKGROUND: Nesfatin-1 is involved in cardiovascular regulation, stress-related responses. The objective of this study is to investigate the impact of volatile anesthetics on Nesfatin-1 levels. METHOD: Fourty-two patients aged 30-65 years with the American Society Anesthesiology (ASA) Class I-II who were scheduled for laparoscopic cholecystectomy were included in the study Patients were randomized into two group; desflurane administered group (Group I, n = 21) and sevoflurane administered group (Group II, n = 21). For anesthesia maintenance, the patients received 6% desflurane or 2% sevoflurane in 40% O2 and 60% air. The patient's heart rate (HR), mean, systolic and diastolic arterial pressures (MAP, SAP, DAP), peripheral O2 saturation (SpO2) were monitored and recorded before induction, after induction, after intubation, and during extubation. Blood samples were collected before induction (T1), and after extubation when aldrete score was 10 (T2). RESULTS: Demographic data were similar between the groups. The preoperative levels of nesfatin were similar in the two groups (p = 0.715). In desflurane group, post-operative nesfatin levels were similar compared to preoperative levels (p = 0.073). In sevoflurane group, post-operative nesfatin levels were similar (p = 0.131). The nesfatin levels (postoperative vs preoperative) were similar between the groups (p = 0.900). CONCLUSION: In conclusion, this study results suggest that nesfatin-1 levels are not affected by the use of sevoflurane or desflurane in patients undergoing laparoscopic cholecystectomy. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry, ACTRN12617001023347 , retrospectively registered on 17 July 2017.
RCT Entities:
BACKGROUND:Nesfatin-1 is involved in cardiovascular regulation, stress-related responses. The objective of this study is to investigate the impact of volatile anesthetics on Nesfatin-1 levels. METHOD: Fourty-two patients aged 30-65 years with the American Society Anesthesiology (ASA) Class I-II who were scheduled for laparoscopic cholecystectomy were included in the study Patients were randomized into two group; desflurane administered group (Group I, n = 21) and sevoflurane administered group (Group II, n = 21). For anesthesia maintenance, the patients received 6% desflurane or 2% sevoflurane in 40% O2 and 60% air. The patient's heart rate (HR), mean, systolic and diastolic arterial pressures (MAP, SAP, DAP), peripheral O2 saturation (SpO2) were monitored and recorded before induction, after induction, after intubation, and during extubation. Blood samples were collected before induction (T1), and after extubation when aldrete score was 10 (T2). RESULTS: Demographic data were similar between the groups. The preoperative levels of nesfatin were similar in the two groups (p = 0.715). In desflurane group, post-operative nesfatin levels were similar compared to preoperative levels (p = 0.073). In sevoflurane group, post-operative nesfatin levels were similar (p = 0.131). The nesfatin levels (postoperative vs preoperative) were similar between the groups (p = 0.900). CONCLUSION: In conclusion, this study results suggest that nesfatin-1 levels are not affected by the use of sevoflurane or desflurane in patients undergoing laparoscopic cholecystectomy. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry, ACTRN12617001023347 , retrospectively registered on 17 July 2017.
Authors: Sandra Feijóo-Bandín; Diego Rodríguez-Penas; Vanessa García-Rúa; Ana Mosquera-Leal; Manuel Francisco Otero; Eva Pereira; José Rubio; Isabel Martínez; Luisa María Seoane; Oreste Gualillo; Manuel Calaza; Tomás García-Caballero; Manuel Portolés; Esther Roselló-Lletí; Carlos Diéguez; Miguel Rivera; José Ramón González-Juanatey; Francisca Lago Journal: Endocrinology Date: 2013-09-24 Impact factor: 4.736
Authors: M S Bonnet; M Djelloul; V Tillement; C Tardivel; L Mounien; J Trouslard; J-D Troadec; M Dallaporta Journal: J Neuroendocrinol Date: 2013-01 Impact factor: 3.627